GRIFFIN MICHELLE RENEE 4
4 · Adaptive Biotechnologies Corp · Filed Mar 6, 2025
Insider Transaction Report
Form 4
GRIFFIN MICHELLE RENEE
Director
Transactions
- Award
Common Stock
2025-03-04+15,394→ 67,349 total - Sale
Common Stock
2025-03-06$7.94/sh−15,664$124,372→ 51,685 total - Award
Stock Option (right to buy)
2025-03-04+23,726→ 23,726 totalExercise: $8.12Exp: 2035-03-04→ Common Stock (23,726 underlying)
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2024.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $7.64 to $8.21, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F3]The option will vest in equal monthly installments over one year from March 4, 2025, subject to continued service as a director through such vesting dates.